Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

12.60
Delayed Data
As of Aug 24
 -0.58 / -4.40%
Today’s Change
6.17
Today|||52-Week Range
14.54
+1.69%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close13.18
Today’s open13.22
Day’s range12.21 - 13.59
Volume82,778
Average volume (3 months)98,882
Market cap$389.4M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)+12.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.34-4.58%
OMEDOncoMed Pharmaceutic...-0.37-3.45%
RETAReata Pharmaceutical...+0.17+0.95%
SRNESorrento Therapeutic...-0.53-7.61%
Data as of 08/24/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs